Moreover, GBHT also has the ability to regulate the TLR 4/NF-κB signalling pathway, which improves intestinal barrier function and reduces intestinal inflammation, thereby improving insulin resistance and lowering blood sugar levels [38]. The gene discussed is NFKB1; the disease is Insulin resistance.